company background image
4978 logo

ReproCELL TSE:4978 Stock Report

Last Price

JP¥155.00

Market Cap

JP¥13.4b

7D

-1.9%

1Y

-34.9%

Updated

28 Mar, 2024

Data

Company Financials +

ReproCELL Incorporated Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ReproCELL
Historical stock prices
Current Share PriceJP¥155.00
52 Week HighJP¥329.00
52 Week LowJP¥152.00
Beta0.36
1 Month Change-8.28%
3 Month Change-11.43%
1 Year Change-34.87%
3 Year Change-62.83%
5 Year Change-34.60%
Change since IPO-89.69%

Recent News & Updates

Recent updates

Update: ReproCELL (TYO:4978) Stock Gained 33% In The Last Five Years

Feb 07
Update: ReproCELL (TYO:4978) Stock Gained 33% In The Last Five Years

Shareholder Returns

4978JP BiotechsJP Market
7D-1.9%-2.6%1.7%
1Y-34.9%-23.9%37.6%

Return vs Industry: 4978 underperformed the JP Biotechs industry which returned -23.9% over the past year.

Return vs Market: 4978 underperformed the JP Market which returned 37.6% over the past year.

Price Volatility

Is 4978's price volatile compared to industry and market?
4978 volatility
4978 Average Weekly Movement3.9%
Biotechs Industry Average Movement7.5%
Market Average Movement3.9%
10% most volatile stocks in JP Market8.4%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 4978 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4978's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200392Shuji Yokoyamahttps://www.reprocell.com

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, and synfire induced neurons; 3D cell culture; and labware. The company also provides research stem cell, genomics, clinical stem cell research, preclinical and drug discovery CRO, precision medicine, human tissue samples, clinical laboratory, diagnostic, and gene editing services.

ReproCELL Incorporated Fundamentals Summary

How do ReproCELL's earnings and revenue compare to its market cap?
4978 fundamental statistics
Market capJP¥13.43b
Earnings (TTM)-JP¥218.00m
Revenue (TTM)JP¥2.51b

5.4x

P/S Ratio

-61.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4978 income statement (TTM)
RevenueJP¥2.51b
Cost of RevenueJP¥1.42b
Gross ProfitJP¥1.09b
Other ExpensesJP¥1.31b
Earnings-JP¥218.00m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 13, 2024

Earnings per share (EPS)-2.52
Gross Margin43.50%
Net Profit Margin-8.70%
Debt/Equity Ratio0%

How did 4978 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.